Flucindole

Flucindole
Clinical data
Other names	WIN-35150; WIN35150; WIN-35,150; 5,7-Difluoro-N,N-dimethyl-α,2-dimethylene-tryptamine
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	In general: uncontrolled;
Identifiers
	IUPAC name 6,8-Difluoro-N,N-dimethyl-2,3,4,9-tetrishydro-1H-carbazol-3-amine;
CAS Number	40594-09-0;
PubChem CID	38531;
ChemSpider	35315 ;
UNII	5CYU0D0S8M;
KEGG	D02658 ;
ChEMBL	ChEMBL1882682;
CompTox Dashboard (EPA)	DTXSID40866001 ;
Chemical and physical data
Formula	C14H16F2N2
Molar mass	250.293 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN(C)C1CCC2=C(C1)C3=CC(=CC(=C3N2)F)F;
	InChI InChI=1S/C14H16F2N2/c1-18(2)9-3-4-13-10(7-9)11-5-8(15)6-12(16)14(11)17-13/h5-6,9,17H,3-4,7H2,1-2H3; Key:FXNCRITWFOVSEP-UHFFFAOYSA-N;
	(verify)

Flucindole (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name; developmental code name WIN-35150) is an antipsychotic of the tetrahydrocarbazolamine family with a tricyclic cyclized tryptamine structure that was never marketed.^[1]^[2] It is the 6,8-difluoro derivative of ciclindole.^[3] The drug is about 5 to 10 times more potent than ciclindole both in vitro and in vivo.^[2]

Quick Facts Clinical data, Other names ...

See also